- Home
- ICAD vs INCR Comparison
ICAD vs INCR Comparison
Compare ICAD & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- INCR
- Stock Information
- Founded
- ICAD 1984
- INCR 1994
- Country
- ICAD United States
- INCR Israel
- Employees
- ICAD N/A
- INCR N/A
- Industry
- ICAD Medical/Dental Instruments
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- INCR Health Care
- Exchange
- ICAD Nasdaq
- INCR Nasdaq
- Market Cap
- ICAD 103.3M
- INCR 83.9M
- IPO Year
- ICAD 1986
- INCR N/A
- Fundamental
- Price
- ICAD $3.69
- INCR $1.55
- Analyst Decision
- ICAD Hold
- INCR
- Analyst Count
- ICAD 1
- INCR 0
- Target Price
- ICAD N/A
- INCR N/A
- AVG Volume (30 Days)
- ICAD 300.2K
- INCR 8.7K
- Earning Date
- ICAD 08-12-2025
- INCR 08-15-2025
- Dividend Yield
- ICAD N/A
- INCR N/A
- EPS Growth
- ICAD N/A
- INCR N/A
- EPS
- ICAD N/A
- INCR N/A
- Revenue
- ICAD $19,528,000.00
- INCR $65,575,323.00
- Revenue This Year
- ICAD $3.60
- INCR $69.54
- Revenue Next Year
- ICAD N/A
- INCR $41.75
- P/E Ratio
- ICAD N/A
- INCR N/A
- Revenue Growth
- ICAD 8.86
- INCR N/A
- 52 Week Low
- ICAD $1.18
- INCR $1.17
- 52 Week High
- ICAD $4.02
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- ICAD 50.46
- INCR 54.09
- Support Level
- ICAD $3.58
- INCR $1.43
- Resistance Level
- ICAD $3.88
- INCR $1.54
- Average True Range (ATR)
- ICAD 0.12
- INCR 0.06
- MACD
- ICAD -0.04
- INCR 0.00
- Stochastic Oscillator
- ICAD 33.33
- INCR 93.31
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.